Department of Nephrology, Ghent University Hospital, Ghent, Belgium.
Registre de dialyse péritonéale de langue Française, Pontoise, France.
Clin J Am Soc Nephrol. 2019 Jun 7;14(6):882-893. doi: 10.2215/CJN.11590918. Epub 2019 May 23.
Volume overload is frequent in prevalent patients on kidney replacement therapies and is associated with outcome. This study was devised to follow-up volume status of an incident population on peritoneal dialysis (PD) and to relate this to patient-relevant outcomes.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This prospective cohort study was implemented in 135 study centers from 28 countries. Incident participants on PD were enrolled just before the actual PD treatment was started. Volume status was measured using bioimpedance spectroscopy before start of PD and thereafter in 3-month intervals, together with clinical and laboratory parameters, and PD prescription. The association of volume overload with time to death was tested using a competing risk Cox model.
In this population of 1054 participants incident on PD, volume overload before start of PD amounted to 1.9±2.3 L, and decreased to 1.2±1.8 L during the first year. At all time points, men and participants with diabetes were at higher risk to be volume overloaded. Dropout from PD during 3 years of observation by transfer to hemodialysis or transplantation (23% and 22%) was more prevalent than death (13%). Relative volume overload >17.3% was independently associated with higher risk of death (adjusted hazard ratio, 1.59; 95% confidence interval, 1.08 to 2.33) compared with relative volume overload ≤17.3%. Different practice patterns were observed between regions with respect to proportion of patients on PD versus hemodialysis, selection of PD modality, and prescription of hypertonic solutions.
In this large cohort of incident participants on PD, with different treatment practices across centers and regions, we found substantial volume overload already at start of dialysis. Volume overload improved over time, and was associated with survival.
容量超负荷在接受肾脏替代治疗的常见患者中很常见,且与预后相关。本研究旨在随访腹膜透析(PD)新发病例人群的容量状态,并将其与患者相关结局相关联。
设计、设置、参与者和测量方法:本前瞻性队列研究在 28 个国家的 135 个研究中心实施。PD 新发病例参与者在开始实际 PD 治疗前入组。在开始 PD 之前和之后每 3 个月使用生物阻抗谱测量容量状态,同时测量临床和实验室参数以及 PD 处方。使用竞争风险 Cox 模型检验容量超负荷与死亡时间的关系。
在该 PD 新发病例的 1054 名参与者中,PD 开始前的容量超负荷量为 1.9±2.3 L,在第一年期间降至 1.2±1.8 L。在所有时间点,男性和患有糖尿病的参与者发生容量超负荷的风险更高。在 3 年的观察期间,因转为血液透析或移植而退出 PD(23%和 22%)的比例高于死亡(13%)。与相对容量超负荷≤17.3%相比,相对容量超负荷>17.3%与死亡风险增加相关(调整后的危险比,1.59;95%置信区间,1.08 至 2.33)。不同地区之间在 PD 与血液透析的患者比例、PD 模式选择和高渗溶液处方方面存在不同的实践模式。
在本 PD 新发病例的大型队列中,由于中心和地区之间的治疗实践不同,我们发现透析开始时就存在大量容量超负荷。容量超负荷随时间改善,且与生存相关。